A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain
Clinical trial NCT06764186 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06764186
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2027-12-31
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.